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Biographical Note 
 
Thad Jackson was born in Dallas, Texas on May 21, 1933 to parents Opal (Miller) and Thad 
Jackson.  He is an immunologist, specializing in pediatric immunology.  He has extensive 
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senior scientist and staff member with the Nestle Corporation and while there served as liaison to 
NIFAC.  He is now vice president of INMED, a non-profit organization providing and 
supporting health and social services for children and adults in the US and overseas. 
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Transcript 
 
Don Nicoll:   It is Thursday, the 30th of January, the year 2003.  We are in Washington, D.C. in 
the offices of the Muskie Foundation, and Don Nicoll is interviewing Dr. Thad Jackson.  Dr. 
Jackson, would you give us your full name and spell it, and also give us your date of birth and 
the names of your parents? 
 
Thad Jackson:   Okay, first name is Thad, T-H-A-D, M for Marshall, and Jackson, J-A-C-K-S-
O-N.  I was born May the 21st, 1933. 
 
DN:    And where were you born? 
 
TJ:   Dallas, Texas. 
 
DN:    And what were your parents' names? 
 
TJ:     My mother's maiden name was Opal Miller, and my father's name was Thad Jackson. 
 
DN:    So, are you a junior? 
 
TJ:     Yeah, I'm a junior. 
 
DN:    Now, you grew up in Texas, I assume? 
 
TJ:     No, I left when I was about twelve and went to California.  My father was with the 
Federal Reserve Bank in Dallas, and he later went to Okinawa for the federal government, and 
came back to San Francisco and we just never left. 
 
DN:    Had he been a native of Texas? 
 
TJ:     Yes, a real native.  Both my parents were, had come from families who were founding 
families of the Texas University. 
 
DN:    And did you have brothers and sisters? 
 
 
 
TJ:     Yes, I have two sisters, both of which are teachers and are retiring, as everybody around 
me seems to be doing right now.  One is in special education, and the other is a history teacher. 
 
DN:    Now, when you were growing up in Texas and then in California, did you attend the 
public schools? 
 
TJ:     Yes. 
 
DN:    And where did you go to college? 
 
TJ:     I went, my undergraduate, to San Francisco, University of San Francisco State, and I have 
a master's from the University of San Francisco, they're different for those who don't know that, 
and I got my Ph.D. at the University of California Berkeley. 
 
DN:    What was your field at Berkeley? 
 
TJ:     It was immunology and infectious diseases. 
 
DN:    So you're a Ph.D., very much involved in medical-related work. 
 
TJ:     That's right, I've spent a good portion of my life in hospitals somewhere, someplace. 
 
DN:    And today you're the executive vice president of INMET. 
 
TJ:     That's right, I work for my wife.  She started the organization about sixteen years ago, and 
I retired for twelve days and she said, “Oh no,” and so about, I guess about five years ago, I 
joined INMET then in that position as executive vice president, and I'm in charge of programs 
for the organization. 
 
DN:    And INMET is dedicated to doing what? 
 
TJ:     It's a 501(c)3, a nonprofit, and basically we're, our programs are to develop communities, 
and we do that in various ways depending on the community that we're working in, but basically 
we work with mothers and young children in a community setting. 
 
DN:    Now, our reason for interviewing you primarily is the fact that you had an association 
with Senator Muskie in connection with NIFAC, the Nestlè Infant Formula Audit Commission. 
 
TJ:     Commonly known as the Muskie Commission, I don't think anybody ever really knew the 
other name. 
 
DN:    And what were you doing at Nestlè when the commission was formed? 
 
TJ:     Well, when I, I was in Bangladesh for five years back in the seventies, from '72 to '77.  I 
 
 
was the medical research director for Johns Hopkins for the subcontinent, in Bangladesh and 
Nepal.  And I came out and was actually living in England doing some work at the London 
School of Tropical Medicine when I saw this ad in, I think it was the Economist, and it was a 
Nestlè ad asking for somebody with my kind of background.  And I was just curious why Nestlè 
would be doing that.  So I answered the ad, and they immediately had me come over and be 
interviewed.  And then that's when I found out about the whole infant formula issue, because it 
was not an issue where I was coming from.  And I had just developed a hospital for severely 
malnourished children and had been using some very specialized formula that Nestlè produced 
for, which was lactose free formula, for these very severely malnourished children. 
 
So I got intrigued by it and I, because I, once I heard the story, at least from their side, it just 
seemed like a terrible waste of resources that two sides were fighting like this, over an issue 
where this was really not the central issue.  It was just part of a very complex thing in which, and 
those resources could, if people would work together as much as they were fighting with those 
resources that they were using, it could be utilized for something much more positive than that.  
And so I got involved from that angle. 
 
DN:    And what year was that? 
 
TJ:     That was in 1980? 
 
DN:    So, two years before the commission was formed. 
 
TJ:     Right.  And I spent a year in Switzerland, but essentially traveling back and forth to the 
States.  And about that time, Nestlè realized they'd made some really gross mistakes, gross in the 
sense that, about the public opinion of them, and they realized they had to do something about it. 
 And they were trying to tackle it strictly from a scientific standpoint, and it obviously had 
become something much more than that.  And while they felt the science was still important, and 
that is the role that I played in the thing, it was also important to get the whole message of this 
complex interaction between economics and environment and mothers and poverty, and all the 
things that go with that.  So they formed a thing called the Nestlè Center for Nutrition, Nestlè 
Coordinating Center for Nutrition, and the idea was that this would be a center that would talk 
about the issues of the Third World, and again, to try to develop a dialogue between some of our 
biggest critics. 
 
And one of our more severe critics and groups that we were most concerned about was Phil 
Wogaman and the Methodist church.  Because about the time that we began to set this company 
up, it was a separate company of which I was the vice president, and they were getting ready to 
look at the whole issue of whether the Methodist church would come out and boycott, which 
some of the other churches had done.  And we just felt that here was an opportunity to talk to the 
churches before they actually took action; it's much more difficult once they take an action. 
 
And so that's when I first met Phil Wogaman.  And Phil, to give him credit, he said this openly, 
he may have said something to you in other interviews, that he fully expected to come out of that 
boycotting Nestlè.  But after we had some dialogue with him and talked about the issues, and 
 
 
offered to turn over all of our internal documents, anything that they wanted to see related to the 
infant formula issue, that we were prepared to do that.  And this was contrasted then to some of 
the critics on the other side, who were less than open to the commission, the Methodist 
commission, and it was on the basis of that that we began a dialogue. 
 
And ultimately the commission came out with a report that said if we had to look at the veracity 
between the two groups, that we would have to come down on the side of Nestlè, and they 
recommended that the church not be boycotting.  And it was at that point then we began to work 
in consultation with Phil Wogaman and others about setting up some sort of a commission that 
would act as a third party that could look at the issues and see if the allegations were really true 
or not.  And Senator Muskie was on the top of the list, we dreamed that we would get him, and 
but he was on the top of the list.  And we had four or five others, but he was our first choice and 
he consented to do it, so we were very fortunate having him as a commissioner. 
 
DN:    So you were involved in the discussions and the negotiations that led up to the formation 
of the commission. 
 
TJ:     Yes, that's right.  Ray Pagone at that time was the president of the Nutrition Center that I 
just mentioned that Nestlè had set up, and I was the vice president.  And a lot of people take 
credit for where the commission came from, the idea.  I think it probably was just one of those 
things that evolved from everybody, it was just, it looked like a natural.  So I won't give, I won't 
take full credit for having thought of the idea because it came from many other of the staff. 
 
DN:    What was Ray Pagone's background? 
 
TJ:     Ray was, he was a, I think he was full bird colonel in the Army, had been in Army 
intelligence, and had also worked in public affairs for various companies, one of which was the 
United Fruit, I believe it was, you may have to check on that, but I think it was United Fruit.  
And of course he was involved in the problems that they had dealing with the Third World issues 
that they were dealing with in terms of salaries and housing and other issues, which I'm not that 
versed on.  But he certainly had a similar kind of experience, and so he was, he had been 
recruited by Nestlè.  I didn't meet Ray until after, I was actually hired before Ray was, I was in 
Switzerland and Ray was hired here in the States.  And then I met with Ray, and then Ray, Ray 
was one of the reasons why, he recommended that I be transferred back to the States, that it 
would be easier to operate from. 
 
DN:    So in essence, you helped with setting up the center, he was the president of the center 
and it was based here? 
 
TJ:     Right. 
 
DN:    And then you were transferred to become part of the center. 
 
TJ:     That's right. 
 
 
 
DN:    And how long was it before Ray left the firm and you, in essence, took over the liaison 
role? 
 
TJ:     Well, Ray was there, there were two periods in the, there was from, when was the 
commission formed?  Do you remember? 
 
DN:    Nineteen eighty-two [1982], as I recall. 
 
TJ:     Eighty-two?  So somewhere around '81 we started this process of putting the Nutrition 
Center, I couldn't give you the exact date, but we started putting that together.  And Ray stayed 
on until the end of the boycott, the first phase of the boycott in which the National Council of 
Churches and the American Public Health Association and others got together and made a joint 
statement, with Nestlè, saying that the boycott is over and they felt that we were doing the right 
things and had things in place.  And someone actually even got up and said, “Nestlè makes the 
very best chocolate,” over television, one of our most severe critics actually.  So that ended in 
late '84 maybe, I'm not sure of the dates.  And Ray continued, I left then and I went back to 
England where I had worked before, at the London School.  And I think Ray may have stayed on 
for another six months or something, and then the company was disbanded, principally because 
Ray wanted to leave and start his own company, and I had no desire to be in the public relations 
company, so I opted out. 
 
And then about eighteen months later, another sort of much smaller scale of boycotts started up 
again.  And I was asked to come back, which I did, and started an office here just up the street 
actually, on K Street, to deal with the issue.  It was never a big thing, but the commission was 
reactivated at that point just so that we could continue looking at allegations that were being 
made.  And that lasted for, probably to '89, somewhere in '90, so it just kind - 
 
DN:    Just before the commission ended? 
 
TJ:     Yeah, just before Ed, the commission was kind of, when the commission ended that was 
essentially the end of the boycott.  There were still some people who, and I'm sure there are still 
people out here that still feel strongly about the issue, but that was, as far as the movement was 
concerned, that was the end of it. 
 
DN:    So you had some dealings with the commission, Senator Muskie, in the formation of the 
commission, and then you went back to England for a while, and then you came back into the 
picture. 
 
TJ:     Right. 
 
DN:    What was your sense about the reasons for selecting Senator Muskie as the chairman of 
the commission? 
 
TJ:     Well, he had such a high profile, having been a candidate for the presidency and vice 
presidency, and was secretary of state, and had an extremely good reputation for being an honest, 
 
 
open.  I don't think anyone has ever accused Muskie of being devious, and just had that 
reputation in the eyes of the public, and we just felt he was a natural.  I'm not sure, I think we 
were given the name of Muskie as a possibility, somebody suggested him to us, because by this 
time he had retired and was working for the law firm, and they felt that he might be interested in 
such a unique kind of situation.  I have to say, I think the whole infant formula issue was a most 
bizarre thing.  And I think as we look back at this thing in history we'll wonder how in the world 
we ever, number one, how the company allowed themselves to get into that mess, and secondly, 
how the public got so involved in such a small portion of the real issue of what kills babies. 
 
DN:    Let's talk about that.  From your perspective, what was the issue and why was it bizarre? 
 
TJ:     Well, the issue was that poverty, ignorance, and disease kills babies.  We, to me it was 
always a cop out for all of us; it was easier to blame a big multi-national company, I mean, who 
feels sorry for, you know, at that time a twelve billion dollar company?  They're now a forty 
billion, some fifty billion, so it didn't hurt them very much.  But it just seemed like a cop out to 
be, to project that this, that all these deaths were occurring principally because these babies were 
being fed infant formula, when the reality was that where we have the highest incidence of infant 
mortality, mothers couldn't even afford infant formula, and there's very little infant formula even 
available to them. 
 
We once estimated that if you took all of the sales of infant formula in the Third World and you 
assumed that the mothers stretched it out as far as they could, it would have only accounted for 
ten percent of the deaths, if you attributed that every kid would die that had infant formula.  So 
you can see how the logic of that, if you carried it out to the full extent.  Now, that doesn't mean 
that the company, I think the company made some really terrible mistakes, and I think they 
would be the first to own up to those mistakes, certainly at this point.  And it was really in a way 
kind of a shame, because of the one company out there that had a history of being in the 
developing world, Nestlè had been in Thailand, for example, seventy-five years, and they were a, 
Galbraith once said that Nestlè was the model for multi-national companies to follow.  That was 
before the infant formula issue. 
 
And so it was, in a way it was kind of a shame, but they were coming from a very isolated 
position in that they were a Swiss company, their headquarters were in Switzerland, though they 
had people here running their company here in the States.  But they just didn't have that 
mentality of how the American public operates, in that it's a give-and-take kind of situation.  And 
if someone says something, you're supposed to stand up and say, “No, that's not right.  This is 
my position.”  Well, they didn't do that.  Instead, they took a legalistic kind of position and a 
scientific position, pulling out all of the data to show this and that and the other, and most of the 
public didn't understand it, number one, and number two, they just thought they had something 
to hide if they did all of this.  And so they made some really terrible mistakes in the early stages 
of the thing that got them into very, they just got so far behind the eight ball on this thing that it 
was very difficult for them to recover. 
 
DN:    How did the commission fit with this situation?  That is, how did they deal with the 
scientific issues that you're talking about?  You say that even at the extreme end, ten percent of 
 
 
the babies who die could be dying for reasons attributable to the formula. 
 
TJ:     Well, I was saying if you took it to its extremity, which, I mean. 
 
DN:    But I'm not so much concerned with the numbers as I am, you presented this as an 
example of the bizarreness of the issue from the point of view of the company.  How did the 
commission come at that question, and the position that the company was taking in comparison 
with the general public? 
 
TJ:    Yeah. I think certainly among the scientists and medical people on the commission, I 
think, number one, their position would have been similar to mine, that Nestlè was very stupid in 
the way they handled the issue, but that it was not the major issue in terms of mortality in the 
Third World.  Having said that, I mean that doesn't relieve the company from the responsibility 
to make sure that they try to do as much as they can to make, that their product is used properly.  
And by that I mean promoting to the wrong sets of people and a whole range of things.  And so I 
think from their, I'm putting words in their mouth, but I think from their standpoint, certainly the 
medical and scientific people there would have said, they still have a responsibility, we don't 
think this is the big issue in terms of, if we solve this issue we're not going to solve the major 
issue of why children are dying, but that it is a distraction away from what should be done and 
where we should be going, and that the company does have a responsibility to be responsible for 
their product and make sure that it's used, as much as they possibly can, make sure that it's used 
properly. 
 
DN:    In the end, from your point of view, did the commissions members in general come to that 
conclusion? 
 
TJ:     Yeah, I think they did.  And I think they really, towards the end they all, I think they 
generally felt that the company was trying to do the right thing.  Now, in any large company like 
this, you have people in the field and you have turnover.  And one of the big problems, and this 
is something that needs to be, this isn't my field, but this should certainly be followed up on, is 
institutional memory, because sales managers turn over pretty fast.  They don't have the history 
of something like this, and you don't keep reinforcing the institutional memory and why it's 
important you have to do these things.  You can get yourself back into a similar situation, and so 
I think that's a very important thing. 
 
I think that lesson was learned in the sense that, and that was one of the roles of the commission, 
was that even though there was turnover, you know, there was that commission there all the 
time, and if they got out of line and somebody reported it, we were on it in a flash.  And the 
company actually, I don't think they actually ever fired anyone, they just told them that they were 
not getting promoted, and they left.  And that happened particularly in Central America, on 
several occasions we had some problems there where they had abrogated the rules and 
regulations that the company had set down for them. 
 
DN:    What was it like bringing Senator Muskie up to speed on the issues at the beginning of the 
commission? 
 
 
 
TJ:     Well, it was an interesting time.  We had a few stormy, not from my standpoint, but from 
his, particularly his standpoint about where, exactly how the commission was going to play the 
role, and it was my job, you know.   I was the messenger sort of thing, and I had to go back and 
explain the situation to people who wanted to do, wanted very much wanted the senator's support 
and the commission's support, and didn't, still really hadn't fully grasped all the nuances of 
things.  And so there was, we were acting as a buffer between those two issues.  But once the 
commission was established there was, I never, I had access, direct access to the CEO, Malford, 
so if anything went wrong I had, I could go directly to Malford and say, “I don't like what's 
happening.” So I didn't have to, I rarely ever did that because you only do that when you really 
need it, but that's how strongly they felt about it.  And so when Muskie had something to say, 
they listened.  And that was true right up to the very end of it. 
 
DN:    Now, one issue obviously from the beginning would be how independent the commission 
would be, and how independent he would be of the company, since the company was paying the 
bills.  And it seems to me the second question is, how comfortable, or not comfortable but 
reasonably assured was the company that he understood the issues as you laid them out? 
 
TJ:     Well, he understood the issues because he was getting it from both sides, particularly 
when it first started.  He would listen to both sides of the argument.  It became maybe a little less 
so as we went along, because he had a better feel for where everybody was coming from, and it 
would depend on the source obviously.  There were some of the sources that were not very 
credible, let's put it that way.  But there were others, but people were genuinely concerned about 
what was happening and whether this was a real issue. 
 
From the standpoint of the fact that Nestlè was paying for it, we looked at that issue and there 
really was no choice, nobody else was going to fund it.  And we couldn't, Nestlè was the one that 
was on the hot seat, much more so than the other pharmaceutical companies, even though in 
many cases, according to the World Health Code, they were in violation at that time.  So they 
weren't anxious to get up front, which you could well understand, so really Nestlè had no choice 
but to put up the money.  But they did try to build as many firewalls as they could between 
themselves and the commission, so that the commission could be perceived as, and I would think 
if you were to talk to many of the activists, and you probably have at this point, they would feel 
that, ultimately they would have to admit that the commission was pretty fair in how they 
approached things. 
 
DN:    What was it like, and can you describe what it was like, in bringing Senator Muskie up to 
speed on the issues involved in the case from the perspective of the company, and from your 
perspective as a scientist? 
 
TJ:     Well, he's a quick study, as you know.  And he also, at that, when we first started we had 
Jack Greenwald who was assistant for Muskie, and so I spent a lot of time bringing Jack on the 
stream as much as Senator Muskie, because Senator Muskie obviously was doing a lot of other 
things as well.  And so it was really sort of an education process between the two of us, and I 
would give my side and Jack, being a good lawyer, would say, well why do you say this, and 
 
 
what is this and what is that.  And so it was a learning process really between myself and Jack 
and Senator Muskie.  And I, certainly in the first, early days, I'd probably be over there at least 
once or twice a week, spending an hour or so, principally with Jack at that point, until we began 
to get the full commission going and the people set up, and then we had formal meetings and that 
was a different thing.  But at the early stages it was as important to bring Jack up, as it was 
everybody else on the commission. 
 
DN:    What was it like watching Senator Muskie working with the members of the commission? 
 
TJ:     Well, that was an interesting interaction, because, you know of course, he had been 
secretary of state and was used to a lot of deference, and on the commission were a lot of people 
who also were used to a fair amount of deference.  Maybe not quite as much as Senator Muskie, 
and who were not terribly awed by titles and so on and so forth.  And so I'm sure at times he was 
a little, I'm not sure, I know, he was, he and some of the other members would have a clash 
because they'd just say, well, we don't agree with you, and we think you're wrong.  And many of 
them being academics, that came very natural to them, and so there was a certain friction 
between the academics and the lawyer approach to things that went on within the commission. 
 
It is interesting to, I was trying to remember some of the specific issues but I can't think of any 
right now.  But there were some pretty strong sessions there.  Phil Wogaman and Muskie could, I 
think they used to do it just for the fun of it sometimes, they'd go back and forth on some issue, 
and it wouldn't even necessarily be a big issue, just something that they disagreed on and they 
both loved to debate something.  And another one was Shelly Morgan.  I don't know, have you 
spoken to Shelly? 
 
DN:    No, I haven't yet. 
 
TJ:     He's in California.  He's getting a little frail now so if you want to talk to him, you 
probably talk to him soon. 
 
DN:    Well, I hope to get out to California this spring. 
 
TJ:     Now, he and Muskie used to go at it quite a bit.  But it was never malicious, it was just the 
different approaches that (unintelligible phrase). 
 
DN:    What were the nature of the issues that they were zeroing in on at that point? 
 
TJ:     I was trying to think of a specific issue.  Usually it had to do with wording and how they 
were using words.  Muskie was a real stickler about how, he said, “You just can't be fuzzy about 
this, you have to, it has to be this.”  And they'd say, “Well, it isn't this or that, I mean you're 
talking about human beings and they don't, it isn't just this or that.”  And this would go, they 
could go back and forth, I can't, I'm sorry, right now I just can't - 
 
DN:    Did this have to do with the way the formula was distributed? 
 
 
 
TJ:     No, it had usually more to do with policy.  Because in many ways, what ultimately came 
out of the commission, was that the commission and Nestlè's instructions became the standard 
for the rest of the industry.  The commission couldn't speak for the rest of industry, or even 
attempt to, to defend or even look into their practices.  If they saw something really gross, they 
would say so, if they thought that was inappropriate and they shouldn't be doing it.  So that 
ultimately, within I would say eighteen months after we actually put in a set of directions and 
description of how the formula should be marketed, virtually all the major companies had 
adopted something very, very similar to it. 
 
That was one of the things that Senator Muskie and I did early on, was to take the World Health 
Code and its various sectors, and break, because we went to, and this is where Senator Muskie 
really began to get very frustrated and became a little more sympathetic to our cause I think, was 
that we went to the World Health Organization, and they said, “Well this is a guideline, we can't 
tell you what to do.” And Senator Muskie said,  “Well why can't you, I mean you're the 
international body, everybody's looking at you, why can't you tell us what these guidelines mean 
in terms of practical application?”  And they said, “Well, we can't do that.  We represent all the 
nations, and we'd have to have the approval of every nation to say that that's what it meant to 
them, because this is a guideline for countries and not a guideline for individuals or companies.” 
So that's when we decided we had to do something that we, because you couldn't just form a 
commission and say, well it's in violation of the Code, because nobody, you couldn't get 
everybody to agree on what the Code was. 
 
So what we did is that we actually, Senator Muskie, myself and Jack Greenwald, began to break 
the Code down, and we looked at it on a paragraph by paragraph basis.  And we said, “Well, this 
is what, this is how we interpret the Code, and in order to do that, this is what the company must 
do to follow the Code.”  And so I actually took that to one of our more severe critics, which is 
UNICEF, incidentally still it's a major critic of Nestlè, and sat down with some of their people, at 
least the people that they had at that time, they're all gone now.  And we, you know, I got an 
agreement from them, and I got it unofficially, because they couldn't, they're part of the UN, too, 
they couldn't say anything officially.  And then some of the World Health Organization groups 
and others, and we went over step-by-step to see if we, if they thought what we were saying was 
totally off base or was reasonable in terms of the Code and where we were coming from.  And 
we got a general consensus, and then we took, I did most of the leg work on that, and then we 
brought it back and Senator Muskie and the commission began then to set that up, and they 
presented it to the company and the company accepted it. 
 
DN:    So the process in broad terms involved you, Senator Muskie, Jack Greenwald, working on 
those issues related to the WHO Code, and trying to interpret that in practical terms and 
negotiating a bit with WHO, UNICEF, and then bringing back recommendations through Senator 
Muskie to the full commission? 
 
TJ:     Right.  And the commission then, and again, and this is where a lot of that discussion 
went back and forth about how the language should read.  And the commission ultimately came 
up with this set of guidelines which they felt comfortable with, and that ultimately then was 
submitted on a formal basis to the company, and the company agreed to abide by that. 
 
 
 
DN:    Was that the major accomplishment of the commission, from your point of view? 
 
TJ:     That was certainly the first big accomplishment.  I think there were two things that 
ultimately resolved the boycott.  One was, the Methodist church and Phil Wogaman's group, and 
the second was the commission setting up these guidelines and then following through and 
judging the company on the basis of those guidelines. 
 
DN:    They became the criteria for evaluating performance. 
 
TJ:     Right.  And some of the things were kind of weird.  For example, we had I think it was in 
Malaysia or Sri Lanka or someplace, or Ceylon I guess it is now, and there was on a wall a big 
thing for one of the infant formulas, (name) I think, or, I don't remember which brand it was.  
But anyway, it was on the, and it had been there for twenty years, and it belonged to this 
pharmacist, and it was his wall.  And he'd put it up there and he'd paid for it, or somebody had 
twenty years ago, and he refused to take it down.  But it was in violation of the Code, from our 
standpoint.  The company offered him money, everything.  “No,” he wasn't going to change it. 
 
Well, of course the activists would come out then and it would be all over their papers and things 
saying, “We saw this sign and,” you know, and so some of the things were really way out.  And 
so what the commission did, rather than being, taking one side or the other, they would just 
simply state the facts, and it is in their opinion that if it is possible, somehow or another that sign 
should come down, if it's possible.  Here's the facts, these are the reasons, and this is what we 
think should be done. 
 
Others were, you know, there were times when Nestlè was in violation of those guidelines, and 
they would very clearly come out and say, this has to stop, and it did.  And this went on for, at 
first the activists saw that this was a, was not a good thing for them, very early on.  At first they 
said, “Oh boy, here we go” you know, because they'd kind of swamp the commission.  And 
when they didn't swamp the commission and it began to be broken down in a rational way, they 
began to realize that they had a problem, and so then they ignored the commission.  They tried 
ignoring the commission for a while, and that didn't work and so they finally came back to the 
commission, and by that time it had begun to lose a lot of its steam, and people were looking at it 
a little more rationally.  And that's when they began to realize that they were really losing ground 
and that they had to get out of it in a graceful way. 
 
DN:    In the end, when the commission concluded its work, how did the company, that is Nestlè, 
feel about the results of that experiment? 
 
TJ:     Well, I think you'd have to, it would depend on who you talk to.  I mean, like in any large 
organizations there are dinosaurs, and I'm sure some of the dinosaurs were not too happy.  They 
probably felt it was the, they had done no wrong and that this was an infringement on their 
ability to operate as a company.  I think certainly at the top, very top management, there was a 
real understanding of the commission's role and an appreciation of what the commission had 
done.  And hopefully there were some lessons learned there that would apply to their activities in 
 
 
the future.  It certainly made them much more aware that a company as big as they are, without 
even trying, can get into trouble with misperceptions or outright, maybe not intentional, but 
actions that affect others. 
 
And so I think for the first, I mean, you know, the world had not seen anything quite like this 
before, in the business world, so this was, I mean this is a real study on what to do and what not 
to do in terms of how you operate as a company.  I mean, their taking it to the court and, you 
know, they really, they won the case but lost the war when they sued that group in Switzerland.  
But, you know, they were a very Calvinistic company in little Switzerland overlooking the lake, 
and they'd been called baby killers, and they felt indignant about it, and that was their response.  
It was the wrong response, but that was maybe a natural response. 
 
And they weren't totally innocent, I mean there were activities that needed to be cleaned up, and 
they did, to their credit.  But, and a lot, a good, I mean, I'm not here to defend them in the sense 
of, because I've never been, I would never call myself or be a company man as such, but a lot of 
the activities they were accused of, they had done in the past but at the time they were accused of 
it they were no longer doing it.  They had already made the change, some of them for very 
practical reasons. 
 
A good example of that would be in the early, in the sixties, they used to, at the request of many 
of the health industries, actually advertise on radio telling mothers exactly how to mix the 
formula, so that, you know, you mix so much with, this scoop with so much water, and you boil 
the water before you pour it in, and all those things.  And they would get the script approved by 
the health ministry.  And in the sixties, they were targeting a population of people that were in a 
cash economy, because they all had radios.  You didn't own a radio unless you were in a cash 
economy.  But by the seventies, you had the Japanese transistor radios that flooded the market 
and you could buy one for two dollars.  That market had changed, and so the messages that they 
were sending out were not appropriate. 
 
Most of the countries where this had occurred, they pulled, they had pulled all these back.  Not 
because they saw it as a real danger, but they simply realized that they were not marketing to the 
people they wanted to market to.  They were marketing to people who had no money, and they 
hadn't rec-, maybe some of them hadn't recognized, but I think the main, and maybe I'm putting 
motivations in people's mouth, I don't know, but my perception was that they did it principally 
because of market pressures that had nothing to do with the boycott issues. 
 
DN:    As you look back on the work you did in connection with the commission and the 
connection with Senator Muskie, what did you learn from him about dealing with this kind of a 
thorny public policy issue? 
 
TJ:     There's one quote from him I'll never forget, and I use it all the time.  And he said, “Thad, 
every time you solve one problem, you create two more issues.”  And I think he's right.  He said, 
“That's been my experience.” 
 
DN:    What was his style dealing with you, and then dealing with the commission? 
 
 
 
TJ:     Well, he could be pretty autocratic sometimes, and of course he could put on a splendid 
display of temper tantrums.  I mean he, he was the world's expert at that.  And some of it was 
staged, I mean, I know most of it was, he used it for effect.  Every once in a while he'd get 
carried up in his own rhetoric and he'd lose it.  So, there were occasions when we had, and I 
would get it when the company would do something stupid.  I can't think, but you know, 
something that was just obvious to everybody that should never have happened, and it did.  And 
of course if I came in on the wrong day, then I had to listen to why it was so stupid.  But he 
never, it never, it was never projected at me personally, it was just the issue and the situation.  
But he could be a very intimidating person if he wanted to be. 
 
DN:    I've got a question for you: his secretary, Carole Parmelee, told me that you were very 
helpful when he was traveling to Switzerland, for example, in arrangements.  Did you ever 
encounter a situation where the travel went awry for reasons beyond your control, or the airline's 
control? 
 
TJ:     The only time that actually happened, and where he got upset about it, it happened 
because, particularly when, actually I never traveled, you know, they did some trips into the 
Third World countries and nobody from Nestlè went.  We toed, we set up a worldwide message 
to the company that, at any time a commission can show up on your door, show their passport, 
and you're to open your books to, any, if they ask, anything that has to do with infant formula 
that ask for, you have to give it to them.  And I deliberately did not go around when they were 
doing that kind of traveling, because I didn't want to know where they were going, I didn't think 
that was appropriate.  But when we were traveling as, when the commission was traveling, 
particularly within the United States or Switzerland to meet with the board in Switzerland, of 
course I did travel with the group. 
 
And once we went to Berkeley, I can't remember why we went to Berkeley, but anyway we went 
there, and it was a holiday or something, and there aren't that many hotels at Berkeley anyway, 
but we ended up in this hotel across the street from the campus, and it was, it doesn't usually get 
hot there, but it got really hot that day and the air conditioning wasn't working.  And I was 
reminded that he was the ex secretary of state and this was no way to be treated. 
 
End of Side A 
Side B 
 
DN:    We are now on the second side of the January 30th interview with Dr. Thad Jackson.  Dr. 
Jackson, we were talking about dealing with Senator Muskie and his use of temper, and 
sometimes his temper getting ahead of him, as it were.  How did the commission evolve as an 
entity?  Here you had very independent, strong willed people coming together on a contentious, 
sometimes contentious issue.  How did they evolve as an institution? 
 
TJ:     I think, remember I said there were two phases, the first phase, and then later on sort of a 
die down and then a resurrection.  The first phase I think there was a very strong institutional 
camaraderie that developed within the commission, even to the extent that myself, even though I 
 
 
was obviously paid, hired by the company, I took a lot of stances.  And I'm sure you have looked 
through the transcripts and things, where I could literally have been fired, I'm sure, had some of 
the other people looked at that, except that I had the backing of the very top of the management.  
We all took it very serious, and you know, if I felt the company wasn't doing, that wasn't the 
right thing, I said so.  And that was true of the whole commission, there was a real effort to be 
even handed, even though at times some of them were, some of their allegations were really 
ludicrous. 
 
Other times they were just difficult because we just didn't have enough facts to act to.  But there 
was a real effort on all of their parts, and like I say, there were some heated discussions between 
some of the more vocal members of the group, but no one, I don't think anyone ever left there 
mad at one another at any time.  It was just this sense of, that this issue had to be dealt with 
properly, that it was an important thing to do.  You know, it's like any group, like a group of 
soldiers or a group of, any group, where the group becomes very important within the group, and 
so the integrity of the group becomes very important.  So from that standpoint, I don't think they 
would have ever sacrificed the integrity of the group to the benefit of the company, or to any 
group outside.  I mean, they were an entity of themselves, in and of themselves, and they were as 
much concerned about their own perception of that integrity as they were about the individual 
issues.  So I think from that standpoint, it was a very unique group. 
 
DN:    Now, you spoke of the two phases.  Was that attitude prevalent in the second phase, too? 
 
TJ:     The second phase, you know, it was kind of anticlimatic, and this thing just kept kind of 
trickling along.  And so allegations were coming through and the commission would look at it, 
but there wasn't quite the same urgency that we had before.  And some of the, we had added to 
the commission, I don't think we lost anybody, but we added to the commission and they worked 
with the original group, so they didn't have quite the same history. 
 
I think at the request of one of the activist groups, we actually put someone, I can't think of his 
name now, he's at Boston, anyway, he was added to the group, and he had not gone through the 
same set of experiences, and so there just wasn't quite the same urgency about it the second half 
of the thing.  As I say, the central boycott issue was over, and these were just, it's Nestlè's kind of 
slipping back was kind of the way I think that the commission was looking at it at that point.  So 
there wasn't quite the same dynamic interaction that we had the first go around. 
 
DN:    Are there any items that we've missed in talking about the commission, and working with 
Senator Muskie? 
 
TJ:     No, it's been so long since I've had a chance to talk about it.  I usually, you know, I just 
don't usually talk, well, not many people ever really knew the issues very much to begin with, 
though it was a very visible thing.  It's amazing, when you'd ask people, well, “Why do you think 
that this was so terrible?”  “Well, it was terrible,” but then they couldn't tell you why.  They just 
knew that something terrible had happened out there, and I think that this is a legacy that 
companies need to look at very, very carefully.  The role that I play now in a nonprofit working 
with private sector, there's just a different, there's a difference of how companies perceive their, 
 
 
particularly large international companies, how they perceive their role in the countries they 
work in now, than say late seventies, early eighties. 
 
DN:    How do they see their role today? 
 
TJ:     Well, I think most of them see that they have a responsibility to do something for the 
communities that they work in, and some of them even feel strongly about the whole country, but 
certainly within the communities, and that that's a cost of operation.  We certainly see that now 
from extraction companies that you would never have seen twenty years ago, like the oil 
industry, energy industries have changed enormously.  Companies like Monsanto, for example, 
who have some real issues not unsimilar to what Nestlè had in the sense that it's perception more 
than fact of where they're coming from with genetically modified foods and things.  They 
certainly have learned that they really do have to have, be responsible in the communities they're 
working in, and be perceived as being responsible so that they get a kind of third party 
endorsement of what they're doing.  So I don't think the environment's quite the same as it was in 
the late seventies, early eighties. 
 
And I think, you know, the Nestlè experience has, I mean you go to any business school and that 
case study is one of the classic studies that every school teaches.  It's going to be unique.  I think 
as we really begin to deal with this, I always felt, if I could have had all the money that was spent 
on this issue on both sides, and somebody had given it to me, I could have set up four national 
public health programs that would have alleviated the death and disease that goes on in these 
really poor countries.  I mean, the amount of money that was spent was tremendous, relative to 
what came out of it.  And that money could have been used, had we all gotten together, and I say 
all, I mean, I put the monkey on the back of everybody that got involved in that issue.  Their 
egos, their perception of who they were, their perception of what their politics were, all of that 
was involved.  It had nothing to do with mothers and children.  All that got involved in all of 
that, so that people could no longer see the issues. 
 
And even in a big forum like the World Health Organization meetings, those, it got to the point 
where people who knew better wouldn't say anything because it wasn't worth it.  I've had, I can't 
tell you how many leading authorities on infant nutrition and health I've talked to who said, “It 
isn't my fight, and I can't get into this issue because people you're dealing with aren't rational.”  
It's become something bigger than what the issue is, and you can't fight that.  It's like fighting 
religion. 
 
DN:    And that problem is continuing? 
 
TJ:     It is on a smaller scale.  I think that, I'm probably not the one to talk about it because I 
haven't been in this issue for a while, but I think the issue that Nestlè's dealing with now has to 
do with weaning foods, and their role in weaning foods.  And it's a little bit of a, it's a little bit 
technical in the sense of when, and it's something again where the World Health Organization 
has had a hard time coming up with a set of directives.  And again, Nestlè had arbitrarily said 
that weaning should begin the ages of four and six months, and UNICEF came out and said it 
should begin at six months.  But we know that a lot of babies are already being fed at, some of 
 
 
them, at two and three months.  And that doesn't mean it's right, but that's what's happening.  So 
if it is what's happening, there should be some instructions out there guiding these mothers on 
how to do it properly.  So that's been an issue that's, you know, that we could spend the rest of 
the evening talking about that.  But it's an issue that's still out there, and I think that's, I could be 
wrong, but I think that's the main issue that UNICEF still has with Nestlè over this whole issue. 
 
DN:    Well, this must have been a fascinating period for you as an immunologist, dealing with 
the issues of child, or infant immunology and then nutrition, malnutrition. 
 
TJ:     It was.  Many times I look back and I think, “How in the world did I ever get myself into 
this position?” Because it did take up a good chunk of my time, my professional time, dealing 
with it.  But it was, it was a fascinating thing.  It was a fascinating study in dynamics of people 
and movements and how things get started, and how do you stop them once they get started.  
Nestlè was really the classic example of what not to do, and then I think ultimately was a good 
example of how to rectify a really bad situation. 
 
And so from that standpoint, if I were a professor in business administration, I would think this 
would have been a fascinating. . . .  I guess it has been; a lot of people have written about it.  But 
the actual, how it ever gained, and I've talked to, over time you actually, you develop respect for 
certain members of your, the critics.  And I've talked to some of the ones, and I asked them, I 
said, “How in the world?”  And they said, well, you know, “We never dreamt that it would ever 
get this big when we started this, it just happened.”  The idea was actually perceived on the plane 
going from Geneva to New York, two of the activists were sitting together on the plane, and they 
decided to pick Nestlè because it wasn't an American company, and they had been so vocal about 
it.  And that's what started it, and I don't think anybody dreamt that it would ever become the 
worldwide issue that it ultimately became. 
 
DN:    Well, thank you very much. 
 
End of Interview 
